V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009764 | 330003753 | 1.76 | null | null | null | 2017-08-17 | OST Mifamurtide | N | N | 330007189 | MIFAMURTIDE |
| 330009765 | 330003753 | 0 | 87 | Neo-adjuvant (N) | 2013-05-07 | 2013-05-10 | METHOTREXATE | 02 | N | 330007189 | METHOTREXATE |
| 330009766 | 330010353 | null | 95.35 | Curative (C) | null | 2016-07-21 | Mifamurtide weeks 1-12 | N | null | 330007202 | MIFAMURTIDE |
| 330009768 | 330010354 | 1.88 | 91.1 | null | null | 2016-10-12 | DOXORUBICIN | null | null | 330007214 | DOXORUBICIN |
| 330009769 | 330003760 | 1.58 | 49.8 | Adjuvant (A) | 2014-02-22 | 2014-02-22 | Mifamurtide weeks 13-36 | 2 | N | 330007218 | MIFAMURTIDE |
| 330009770 | 330003763 | 1.65 | 85.3 | Curative (C) | 2016-09-20 | 2016-09-21 | Trial Unspecified | N | N | 330007231 | TRIAL |
| 330009771 | 330003764 | 1.61 | 75.1 | Palliative (P) | 2013-10-20 | 2014-04-04 | MIFAMURTIDE | 02 | N | 330007247 | MIFAMURTIDE |
| 330009772 | 330003767 | 1.79 | 71 | Adjuvant (A) | 2014-10-21 | 2014-10-27 | METHOTREXATE | 2 | Y | 330007248 | METHOTREXATE |
| 330009773 | 330003770 | 1.8 | 84.4 | Neo-adjuvant (N) | null | 2015-12-13 | DOXORUBICIN | 02 | N | 330007251 | DOXORUBICIN |
| 330009774 | 330008035 | 0 | 80 | Neo-adjuvant (N) | 2015-04-30 | 2015-04-30 | EW EuroEwing 2012 Arm A VAI | 2 | N | 330007251 | TRIAL |
| 330009775 | 330008035 | 1.69 | 53.3 | Curative (C) | 2015-05-14 | 2015-05-21 | METHOTREXATE | 02 | N | 330007251 | METHOTREXATE |
| 330009776 | 330003773 | null | 86 | Adjuvant (A) | 2016-05-29 | 2017-04-01 | Mifamurtide weeks 13-36 | N | N | 330007271 | MIFAMURTIDE |
| 330009778 | 330003776 | 1.9 | 62.3 | Neo-adjuvant (N) | 2015-06-09 | 2015-07-16 | Methotrexate + Folinic acid | N | N | 330007290 | METHOTREXATE |
| 330009779 | 330003777 | 1.74 | 81.7 | Adjuvant (A) | null | 2016-06-25 | Cisplatin | 02 | N | 330007307 | CISPLATIN |
| 330009780 | 330003778 | 1.66 | 67 | Neo-adjuvant (N) | 2014-12-26 | 2015-04-25 | METHOTREXATE | N | N | 330007311 | METHOTREXATE |
| 330009781 | 330003781 | 1.8 | null | Adjuvant (A) | 2016-12-14 | 2017-12-22 | OST Euramos 1 Closed Trial - A | 1 | N | 330007320 | DOXORUBICIN |
| 330009782 | 330003783 | 1.86 | 153.2 | Palliative (P) | null | 2014-02-26 | OST Euramos 1 Closed Trial - A | N | N | 330007323 | DOXORUBICIN |
| 330009783 | 330003785 | 0 | 86 | null | 2013-11-28 | 2013-11-28 | Mifamurtide weeks 1-12 | N | N | 330007345 | MIFAMURTIDE |
| 330009784 | 330010362 | 0 | 102 | Neo-adjuvant (N) | 2014-10-10 | 2015-03-02 | METHOTREXATE | 1 | N | 330007345 | METHOTREXATE |
| 330009785 | 330003788 | null | 42.4 | Curative (C) | 2015-04-06 | 2016-03-09 | Cisplatin | null | null | 330007347 | CISPLATIN |
| 330009786 | 330003790 | 1.76 | 58.4 | Curative (C) | 2015-10-11 | 2015-10-16 | Cisplatin | 02 | N | 330007357 | CISPLATIN |
| 330009787 | 330003791 | 1.78 | 32 | null | 2015-12-31 | 2016-01-05 | Cisplatin 7 day | 01 | N | 330007358 | CISPLATIN |
| 330009788 | 330008048 | 1.61 | 64 | Palliative (P) | 2013-10-06 | 2014-06-06 | Trial Unspecified | N | N | 330007358 | TRIAL |
| 330009789 | 330012367 | 0 | 63.4 | Curative (C) | 2014-02-27 | 2014-08-18 | OST Mifamurtide | Y | N | 330007365 | MIFAMURTIDE |
| 330009790 | 330003794 | 1.72 | 73.5 | Neo-adjuvant (N) | 2016-10-31 | 2016-11-15 | DOXORUBICIN | 01 | N | 330007368 | DOXORUBICIN |
| 330009791 | 330003796 | 1.8 | 82 | Curative (C) | 2018-02-28 | 2018-03-21 | Trial Unspecified | 02 | Y | 330007378 | TRIAL |
| 330009792 | 330008052 | 1.58 | 11.2 | Curative (C) | 2016-03-08 | 2016-03-08 | MIFAMURTIDE | 02 | N | 330007381 | MIFAMURTIDE |
| 330009793 | 330003800 | 1.65 | 49.6 | Disease modification (D) | 2017-03-17 | 2017-04-07 | EW EuroEwing 2012 Arm B IE | 02 | N | 330007382 | TRIAL |
| 330009794 | 330003801 | null | 50.3 | Curative (C) | 2017-11-07 | 2018-02-24 | DOXORUBICIN | N | null | 330007388 | DOXORUBICIN |
| 330009795 | 330003802 | 1.67 | 57.7 | Palliative (P) | 2015-05-19 | 2015-05-19 | Trial Unspecified | N | null | 330007390 | TRIAL |
| 330009796 | 330008055 | 1.82 | 63.4 | Palliative (P) | null | 2016-08-18 | Mifamurtide weeks 13-36 | 2 | N | 330007390 | MIFAMURTIDE |
| 330009797 | 330003805 | 1.72 | 53.3 | Adjuvant (A) | 2017-03-06 | 2018-02-06 | Doxorubicin 75mg/m2 | N | N | 330007412 | DOXORUBICIN |
| 330009798 | 330003808 | 0 | null | Palliative (P) | 2013-06-02 | 2013-06-02 | METHOTREXATE | 02 | N | 330007417 | METHOTREXATE |
| 330009799 | 330008058 | 0 | 82.6 | Curative (C) | 2014-07-14 | 2014-08-15 | Cisplatin | 02 | N | 330007427 | CISPLATIN |
| 330009800 | 330003811 | null | 47.7 | Adjuvant (A) | 2015-07-22 | 2015-12-07 | MIFAMURTIDE | N | N | 330007437 | MIFAMURTIDE |
| 330009801 | 330003811 | 1.65 | 92.1 | Palliative (P) | 2013-10-05 | 2013-10-05 | EW EuroEwing 2012 Arm B IE | 02 | N | 330007437 | TRIAL |
| 330009803 | 330003812 | 1.69 | 74.7 | Curative (C) | 2016-10-08 | 2016-10-30 | METHOTREXATE | null | null | 330007452 | METHOTREXATE |
| 330009804 | 330003816 | 1.84 | 84.1 | Palliative (P) | 2016-05-15 | 2016-05-16 | Trial Unspecified | null | null | 330007467 | TRIAL |
| 330009805 | 330003818 | 1.81 | null | Curative (C) | 2012-02-11 | 2015-02-05 | OST Mifamurtide | 2 | N | 330007472 | MIFAMURTIDE |
| 330009806 | 330003821 | 1.8 | null | Neo-adjuvant (N) | 2014-12-14 | 2015-04-26 | METHOTREXATE | N | Y | 330007479 | METHOTREXATE |
| 330009807 | 330008068 | 1.8 | 87 | Curative (C) | 2015-01-17 | 2015-01-18 | Trial Unspecified | N | N | 330007485 | TRIAL |
| 330009808 | 330003826 | 1.81 | 89.4 | Neo-adjuvant (N) | null | 2013-10-26 | Doxorubicin 75mg/m2 | N | N | 330007486 | DOXORUBICIN |
| 330009809 | 330010379 | 1.58 | 65.8 | Adjuvant (A) | 2018-05-02 | 2018-05-02 | Doxorubicin 75mg/m2 | N | Y | 330007490 | DOXORUBICIN |
| 330009810 | 330010379 | 1.82 | 67.6 | Curative (C) | 2013-10-05 | 2013-10-05 | METHOTREXATE | Y | N | 330007490 | METHOTREXATE |
| 330009811 | 330003829 | null | 55.5 | null | 2012-04-30 | 2015-10-13 | EW EuroEwing 2012 Arm B IE | null | null | 330007491 | TRIAL |
| 330009812 | 330003830 | 0 | 75.5 | Curative (C) | null | 2017-02-17 | OST Mifamurtide | 2 | N | 330007503 | MIFAMURTIDE |
| 330009813 | 330003831 | 0 | 90 | Adjuvant (A) | 2015-11-12 | 2016-04-07 | Mifamurtide weeks 13-36 | N | N | 330007505 | MIFAMURTIDE |
| 330009814 | 330008075 | 1.63 | 87 | Curative (C) | 2016-04-14 | 2016-04-20 | Trial Unspecified | 1 | N | 330007519 | TRIAL |
| 330009816 | 330010382 | 1.8 | 82 | Curative (C) | 2015-10-31 | 2015-10-31 | Cisplatin | Y | N | 330007528 | CISPLATIN |
| 330009817 | 330003837 | 0 | 64.1 | Adjuvant (A) | 2015-09-25 | 2015-10-02 | Mifamurtide weeks 13-36 | 2 | N | 330007540 | MIFAMURTIDE |